Enteric bacteria are the most important cause of recurrent urinary tract infections (UTIs) via the ascending route.
Patients and methods
The study group was composed of 48 patients (26 girls) with a mean age of 7. 6 1.0 years (range 18 months to 12.5 years). The patients were given antibiotic therapy for upper respiratory tract infections (URTIs; 30 cases) or UTIs (18 cases). Thirty-two patients (18 with a UTI) were given oral ampicillin-sulbactam at a dose of 50 mg/kg/day, bd, and 16 patients with a URTI were given oral ampicillin at a dose of 100 mg/kg/day, qid, for 7 days. Consent of the medical ethics committee and of parents was obtained before the study. The predominant bacteria in stool cultures were isolated from all the patients at the beginning and end of the treatment period. The susceptibilities of the isolated bacteria to the antibiotics were determined by measuring MICs. The bacteria isolated were considered as resistant if the MICs of ampicillin and ampicillin-sulbactam were more than 32 and 16 mg/L respectively.
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Isolation and identification of bacteria
Stool samples obtained from the patients were diluted 1:10 to 1:100 to obtain single colonies. Diluted samples were cultured on eosin-methylene blue (EMB) and salmonella-shigella (SS) agar plates and incubated at 37 C for 18 h. Only Escherichia coli species, which were the dominant bacteria in all the samples, were used to standardize the experiment. During the preliminary phase of the experiment, five E. coli colonies were selected from each sample and the sensitivity of these colonies to ampicillin and ampicillin-sulbactam was determined by the MIC method. No significant difference between these colonies was seen. Thus, a single E. coli colony was selected randomly from the agar plates from all 48 patients. bacterial strains to be tested were prepared for inocula to a density of 0.5 on the McFarland scale. MICs were determined after incubating the plates at 37 C for 18 h.
Determination of MIC
Statistics
Wilcoxon signed rank and paired Student's t-test were used for paired groups, and a chi-square test for nonparametric comparisons.
Results
E. coli was the dominant bacterium in enteric flora in all cases. The resistance rates of E. coli were 87.5% (14/16) and 100% (16/16) for ampicillin and 21% (6/32) and 37.5% (12/32) for ampicillin-sulbactam before and after antibiotic treatment, respectively. The difference between resistance rates before and after treatment, were not statistically significant in either group (P 0.95 and P 0.5 respectively) (Table) .
Before antibiotic treatment there was a significant difference (P 0.01) between ampicillin and ampicillinsulbactam resistance rates in E. coli; after treatment this difference was not significant (P 0.1) (Table) .
The mean MICs were significantly higher after treatment than before treatment (P 0.05) (Table) .
Discussion
UTIs are usually caused by enteric flora contaminating the perianal region and colonizing the bladder via the ascending route, E. coli being the most common agent. 1 It has been known for a long time that antibiotic treatment for any reason could lead to the development of resistance in the flora of the host. [3] [4] [5] Penicillin and its derivatives are the most frequently prescribed antibiotics owing to their efficacy and safety in childhood, 6 and thus it is possible that bacteria might gain significant resistance to this group of antibiotics.
In the present study, the pretreatment resistance rate of E. coli was found to be 87.5% and 21% in ampicillin and ampicillin-sulbactam groups, respectively; this difference was statistically significant. E. coli strains isolated from UTIs were found to have a resistance rate of 50% and 21% for ampicillin and ampicillin-sulbactam groups, respectively, in an epidemiologic study performed in Malaysia. 7 Deguchi et al. reported that the ratio of -lactamase-producing strains had been 100% in E. coli. 8 They also concluded that the antimicrobial activity of sulbactam-ampicillin against many bacteria, including E. coli, was higher than that of ampicillin. Pfaller et al. had reported that ampicillin-sulbactam had an effect on 74-84% of E. coli strains. 9 In one local epidemiological study, the resistance rates of E. coli strains isolated in children with UTIs has been found to be 92% and 40% to ampicillin and ampicillin-sulbactam respectively. 10 Our findings are in accordance with these results.
The difference between the resistance rates mentioned above indicates the importance of -lactamase inhibition. However, it is not known what the potential of resistance development in predominant enteric bacteria is when this combination is used for treatment of UTIs.
In our study, after the completion of antibiotic treatment, E. coli strains isolated were still more resistant to ampicillin than to ampicillin-sulbactam (100% and 37.5% respectively), but the difference was not statistically significant. Furthermore, although post-treatment MICs were significantly higher than the pretreatment values in both ampicillin and ampicillin-sulbactam groups, this evaluation was more pronounced (approximately fourfold) in the ampicillin-sulbactam group. However, this difference is not statistically significant (P 0.05).
It is also clear that combination of ampicillin with sulbactam enhances its inhibitory effect on Gram-negative bacteria.
In conclusion, the results of this study imply that therapy with oral ampicillin-sulbactam could cause the development of resistance to ampicillin in enteric bacteria, as seen here with a two-fold increase in MICs. This finding may have significance to physicians when prescribing antibiotics containing sulbactam as a -lactamase inhibitor for recurrent UTIs in childhood. 
